ProfileGDS4132 / 210918_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 33% 34% 35% 32% 31% 28% 33% 35% 31% 31% 29% 27% 34% 36% 33% 27% 30% 33% 32% 28% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10182.235133
GSM201543Muscle PCOS pioglitazone 12178.105134
GSM201544Muscle PCOS pioglitazone 16190.709435
GSM201545Muscle PCOS pioglitazone 20186.881832
GSM201829Muscle PCOS pioglitazone 23181.33631
GSM201830Muscle PCOS pioglitazon 25169.741528
GSM201831Muscle PCOS pioglitazone 27182.435133
GSM201832Muscle PCOS pioglitazone 3188.171335
GSM201833Muscle PCOS pioglitazone 4171.582131
GSM201834Muscle PCOS pioglitazone 8175.057131
GSM201835Muscle PCOS after pioglitazone 10256.36929
GSM201836Muscle PCOS after pioglitazone 12255.861427
GSM201837Muscle PCOS after pioglitazone 16271.500334
GSM201838Muscle PCOS after pioglitazone 20282.257436
GSM201839Muscle PCOS after pioglitazone 23275.01433
GSM201840Muscle PCOS after pioglitazone 25262.276827
GSM201841Muscle PCOS after pioglitazone 27259.512930
GSM201842Muscle PCOS after pioglitazone 3265.869633
GSM201843Muscle PCOS after pioglitazone 4276.738932
GSM201844Muscle PCOS after pioglitazone 8263.225928